Thermal Keratosis
Thermal keratosis (TK), also called infrared keratosis or chronic heat-induced keratosis, is a precancerous skin lesion caused by long-term, repeated exposure to heat or infrared radiation (IR) at levels too low to cause an acute burn. It represents an abnormal change in the epidermis that develops on top of erythema ab igne (EAI), the mottled rash produced by chronic heat exposure.
From both a scientific and a clinical oncology standpoint, thermal keratosis shares the histology and malignant potential of actinic keratosis (AK). Both are forms of keratinocyte dysplasia that can progress to invasive cutaneous squamous cell carcinoma (cSCC) or Bowen disease (cSCC in situ). The difference is the trigger: instead of solar ultraviolet (UV) light, thermal keratosis is driven by chronic heat energy that damages DNA and weakens local immune surveillance.
At Haute-Derma, our approach to diagnosing and managing thermal keratosis rests on early recognition of the reticulated erythematous vascular pattern on dermoscopy, biopsy to grade the degree of dysplasia under the microscope, and destruction of lesions with ultrapulse CO2 laser or photodynamic therapy (PDT) to eliminate cells on the path to cancer.
Clinical and Pathologic Features
Causes and Risk Factors
- Sources of Chronic Heat Exposure:
- Occupational: furnace workers, blacksmiths, glassblowers, cooks and bakers who work near coal ovens for long periods, and welders.
- Lifestyle and medical: prolonged use of hot packs or heating pads and infrared lamps for chronic joint pain; warming up by coal or wood stoves in winter; resting a laptop directly on the thighs for long periods.
- How Heat Damages Cells and Promotes Cancer (Thermal Carcinogenesis):
- Combined effect of infrared radiation (IR) and heat: infrared light (760 nm–1 mm) raises the local temperature of the skin.
- Oxidative damage (ROS): chronic heat triggers production of reactive oxygen species inside epidermal keratinocytes, and the resulting oxidative stress breaks DNA strands.
- Mutations in the tumor suppressor gene TP53: accumulated heat damage leads to TP53 mutations, much like the effect of UV light in actinic keratosis.
- Increased matrix metalloproteinases (MMPs): heat stimulates MMP-1, MMP-3 and MMP-9, which break down dermal collagen and elastin (thermal elastosis) and weaken the support beneath the epidermis.
- Local immunosuppression: heat reduces the number and function of Langerhans cells in the skin, so the immune system fails to detect and clear genetically altered keratinocytes.
Clinical Features
Lesions usually develop in two successive stages on skin that has been exposed to heat for a long time:
- Precursor stage: erythema ab igne (EAI): the skin first develops a pinkish-red, net-like (reticulated) pattern that later turns reddish-brown and then dusky gray as hemosiderin and melanin are deposited in the dermis.
- Thermal keratosis (TK) stage:
- Arises directly within the hyperpigmented, net-like EAI skin.
- Appearance: thin scaly papules or plaques, 2–10 mm across, pale gray, brown or skin-colored, with a rough surface that feels like sandpaper.
- The edges are often poorly defined, and the scale is firmly stuck to the skin underneath (scraping it off causes bleeding).
- Malignant transformation:
- A lesion that becomes markedly thickened, ulcerated or fissured, or develops a raised, firm, infiltrated nodule, is a warning sign of transformation into squamous cell carcinoma (cSCC) or basal cell carcinoma (BCC). The rate of malignant transformation is similar to that of actinic keratosis (0.1–10%).
Histopathology
Under the microscope, thermal keratosis is almost indistinguishable from actinic keratosis:
- Alternating parakeratosis and orthokeratosis: the stratum corneum is abnormally thick, with columns of parakeratosis sitting directly over the dysplastic epidermis.
- Basal keratinocyte dysplasia:
- Keratinocytes in the basal and suprabasal layers lose their polarity and show hyperchromatic, atypical nuclei of varying size.
- The rete ridges elongate down into the superficial dermis.
- Dyskeratosis: scattered prematurely keratinized cells appear within the spinous layer.
- Heat-induced collagen/elastin degeneration in the dermis (thermal elastosis):
- The superficial dermis contains bands of amorphous, degenerated collagen that stain blue-gray (similar to sun-induced solar elastosis).
- Dilated small blood vessels and hemosiderin-laden macrophages (reflecting the underlying EAI).
Differential Diagnosis and Immunohistochemistry (IHC)
| Condition | Distinguishing Histologic Features, IHC Markers and History |
|---|---|
| Thermal keratosis | Arises on net-like EAI skin with a history of chronic heat exposure; basal cell dysplasia; p53 (mutant pattern); Ki-67 (+) in the basal layer; thermal elastosis. |
| Actinic keratosis (AK) | Clinically and histologically identical to TK but found on sun-exposed skin (face, neck, backs of the hands); no underlying EAI pattern; history of sun/UV exposure. |
| Bowen disease (cSCC in situ) | Full-thickness keratinocyte dysplasia; diffuse p16INK4a (+) if HPV-related, mutant p53; intact basement membrane. |
| Invasive cSCC | Atypical tumor cells break through the basement membrane into the dermis; p63 (+); p40 (+); CK5/6 (+). |
| Seborrheic keratosis | Benign "stuck-on" lesion with pseudohorn cysts; no cellular dysplasia; p53 (wild-type). |
Our Approach to Treating Thermal Keratosis
Haute-Derma manages thermal keratosis on two principles: remove the heat source, and destroy the lesions while preserving healthy tissue.
- Complete Avoidance of Chronic Heat Exposure: this is the essential first step. Patients must stop using infrared lamps, give up prolonged hot-pack habits, change how they work (no laptop on the thighs), or use protective clothing and heat shields in industrial settings.
- Dermoscopic Screening of the Entire Reticulated Area: the whole area of erythema ab igne is closely monitored so that new thermal keratoses are caught as early as possible.
- Complete Destruction of Dysplastic Lesions to Prevent Cancer: advanced precision ablation technologies clear genetically altered keratinocytes while preserving a good cosmetic result in the treated skin.
How We Diagnose Thermal Keratosis at Haute-Derma
- Medical and Occupational History: identifying the source of prolonged heat or infrared exposure (heat lamps, hot packs, laptops, furnace work, cooking).
- High-Resolution Dermoscopy:
- Erythema ab igne background: a dark red/brown reticulated vascular network with bands of hyperpigmentation along its borders.
- Thermal keratosis lesions: grayish-white scale with a rhomboid or rounded "strawberry pattern", follicular openings plugged with keratin, and interspersed small dotted vessels.
- Punch Biopsy for Histopathology: required when a keratotic papule is raised, fissured or suspected of having progressed to squamous cell carcinoma (cSCC).
- Immunohistochemistry (p53, Ki-67): measures proliferative activity and TP53 mutation status to stratify the risk of malignancy.
Specialized Treatments at Haute-Derma
- UltraPulse CO2 Laser Ablation: precisely removes the heat-damaged, dysplastic epidermis. The ultrapulse CO2 laser controls depth at the micro level, gently vaporizing the keratosis without harming the surrounding healthy tissue or leaving contracted scars.
- Photodynamic Therapy (PDT): a photosensitizing cream containing 5-ALA (5-aminolevulinic acid) is applied to the affected skin, left on for 3 hours, and then activated with red light (630 nm). PDT selectively destroys heat-damaged dysplastic keratinocytes across a wide area without affecting the collagen structure of the dermis.
- Topical Field-Directed Therapy:
- 5-fluorouracil cream (5-FU 5%): applied once or twice daily for 2–4 weeks. It blocks DNA synthesis in abnormally proliferating keratinocytes.
- Imiquimod 5% cream: stimulates the local immune response to clear genetically altered cells.
- Diclofenac 3% in hyaluronic acid gel: a gentle option for superficial keratoses.
- Oral / Topical Retinoids: low-dose acitretin is prescribed for widespread, multifocal thermal keratosis to help prevent progression to cancer.
